Catch up on the 9 FDA drug approvals most relevant to primary care, including new options for HIV-1 infection, narcolepsy, diabetes, pain management, and more.
News|Poll|May 16, 2014
Infected Tattoo in a Patient With Diabetes
This patient with type 1 diabetes noted a painful erosion at the site of tattoo she had gotten several days earlier. What's the most likely cause?
Advertisement
This patient with type 1 diabetes noted a painful erosion at the site of tattoo she had gotten several days earlier.
What's the most likely cause?
Advertisement
Related to this article
The FDA has approved insulin efsitora alfa-gobe (Onswik) for adults with type 2 diabetes.
New research links type 2 diabetes and genetic risk to MASLD cirrhosis before 50, warning age-based fibrosis scores can miss severe disease.
Finerenone wins FDA clearance for type 1 diabetes–related CKD, lowering albuminuria in FINE-ONE and opening a long-awaited treatment path.
EADV 2026: Lebrikizumab improved hand and foot clearance, itch, and pain at 16 weeks versus placebo in a phase 3b atopic dermatitis trial.
The FDA has approved baricitinib for adolescents aged 12 and older with severe alopecia areata, marking the first systemic oral therapy cleared for this population.
Advertisement
Advertisement
Trending on Patient Care Online
1
New Schizophrenia Treatment Addresses Long-Standing LAI Barriers
2
CagriSema Cuts Weight Up to 27% Across Menopause Stages: TMS 2026
3
New Study Finds Low Initiation, Persistence With Menopause Hormone Therapy
4
When Night Sweats Signal Something Other Than Menopause
5